article thumbnail

MS patients are being ‘denied’ access to NHS Sativex Says Media Report

Cannabis Law Report

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”.

Access 105
article thumbnail

New UK patient network aims to address issues with access and safety

Cannabis Law Report

A new patient network, NOPAIN has been set up with the aim of uniting patients to discuss issues surrounding safe, legal cannabis access. When the mould issue occurred, this caused quite a big issue for myself because I’m suspected to have an autoimmune condition that I’m trying to get diagnosed. Writes Cannabis Health News.

Patients 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ryan’s Law Will Increase Terminally Ill CA Patients’ Access to Cannabis

Veriheal

Gavin Newsom signed a bill known as Ryan’s Law requiring hospitals in the state to allow terminally ill patients access to medical cannabis for treatment and pain relief. Enlisting the help of Hueso, Jim Bartell began exploring the possibility of allowing terminally ill patients access to cannabis without jeopardizing federal funding.

Access 115
article thumbnail

Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange

Cannabis Law Report

(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). Media contacts: Rachel Moskowitz. Ania Gilbert – Canada media.

article thumbnail

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Cannabis Law Report

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms. The Guardian reports. Cannatrek Ltd (22 notices, $293,040) and.

article thumbnail

Czech Republic softens regulations on medical cannabis says media report

Cannabis Law Report

According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases. In comparison, about 450 patients were prescribed a total of less than 5 kg of cannabis for therapeutic purposes in 2018.

Media 52
article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. Media enquiries: Buchanan Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz.

Access 105